Emovi: Emovi raises $15 million CAD Series C led by TVM Capital Life Science
Montreal-based Emovi has announced a $15 million CAD Series C with TVM Capital Life Science and co-investors StandUp Ventures and Desjardins Capital. This investment...
Read full article »
KneeKG is a knee assessment device that measures joint’s movement for the treatment of osteoarthritis and meniscus injuries.
Read more